Downloading & Printing Fact Sheets
100. Background Information 120. Laboratory Tests 150. Preventing HIV Infection 200. Living with HIV 400. Medications to Fight HIV 480. Strengthening the Immune System 500. Opportunistic Infections and Related Diseases, and Their Treatment 550. Side Effects and Their Treatment 600. Patient Populations 650. HIV and Related Diseases 700. Alternative and Complementary Therapies 800. Nutrition 900. Internet Bookmarks for AIDS
Using Your Browser's “Print” Command
You can use the "Print" command on your Internet browser software to print out any Fact Sheet you are viewing. It will print out as you see it on your screen. The printout will not fit on a single page.
The “Print Version” Of Fact Sheets
The InfoNet Fact Sheets were designed to fit on a single page in a 3-column format. This format seems to be the easiest to print out and read. Fact Sheets can be downloaded and printed in this format using either Microsoft Word 97 (*.doc) format, or Adobe Acrobat (*.pdf) format.
NOTE: If you want to save Fact Sheets on your computer, right-click on the download buttons below. Your browser should then give you the option of saving the file.
A Note On Formats
To use Microsoft Word 97 (*.doc) documents, you must have Microsoft Word 97 software installed on your computer. Earlier versions of Word cannot be used to view and print Word 97 documents, unless you download and install Word 97 Converter from Microsoft.
Adobe Acrobat (*.pdf) documents are less than half the size of Word 97 documents, so they can be downloaded much faster. To use them, you must have Adobe Acrobat Reader software installed on your computer. This software is available at no charge from Adobe.
Get Acrobat Here
Downloading Individual Fact Sheets
This page can be used to download Fact Sheets in English.
You can also download them in Spanish.
Currently viewing Fact Sheets ordered by revision date.
Click here to view Fact Sheets ordered by Fact Sheet number.
| FACT SHEET |
REVISION DATE |
DOC File |
PDF File |
| 731. Marijuana |
May 8, 2008 |
731.doc |
731.pdf |
| 616. Older People and HIV |
May 8, 2008 |
616.doc |
616.pdf |
| 610. Women and HIV |
May 8, 2008 |
610.doc |
610.pdf |
| 508. Herpes Simplex (Cold Sores and Genital Herpes) |
May 8, 2008 |
508.doc |
508.pdf |
| 801. Vitamins and Minerals |
April 28, 2008 |
801.doc |
801.pdf |
| 700. Alternative and Complementary Therapies |
April 28, 2008 |
700.doc |
700.pdf |
| 552. Anemia |
April 28, 2008 |
552.doc |
552.pdf |
| 534. Fluconazole (Diflucan) |
April 28, 2008 |
534.doc |
534.pdf |
| 516. Progressive Multifocal Leucoencephalopathy (PML) |
April 28, 2008 |
516.doc |
516.pdf |
| 507. Hepatitis C |
April 28, 2008 |
507.doc |
507.pdf |
| 504. Cytomegalovirus (CMV) |
April 28, 2008 |
504.doc |
504.pdf |
| 503. Cryptococcal Meningitis |
April 28, 2008 |
503.doc |
503.pdf |
| 502. Cryptosporidiosis |
April 28, 2008 |
502.doc |
502.pdf |
| 501. Candidiasis (Thrush) |
April 28, 2008 |
501.doc |
501.pdf |
| 482. Interleukin-2 |
April 28, 2008 |
482.doc |
482.pdf |
| 421. Truvada (Tenofovir + Emtricitabine) |
April 28, 2008 |
421.doc |
421.pdf |
| 420. Emtricitabine (Emtriva) |
April 28, 2008 |
420.doc |
420.pdf |
| 407. Drug Interactions |
April 28, 2008 |
407.doc |
407.pdf |
| 207. Vaccinations and HIV |
April 28, 2008 |
207.doc |
207.pdf |
| 999. Internet Bookmarks for AIDS |
April 25, 2008 |
999.doc |
999.pdf |
| 202. Choosing an HIV Care Provider |
April 25, 2008 |
202.doc |
202.pdf |
| 200. Important Resources in the USA |
April 25, 2008 |
200.doc |
200.pdf |
| 735. Silymarin (Milk Thistle) |
April 20, 2008 |
735.doc |
735.pdf |
| 519. Wasting Syndrome |
April 20, 2008 |
519.doc |
519.pdf |
| 127. Monitoring Drug Levels |
April 20, 2008 |
127.doc |
127.pdf |
| 122. Chemistry Panel |
April 20, 2008 |
122.doc |
122.pdf |
| 120. Normal Laboratory Values |
April 20, 2008 |
120.doc |
120.pdf |
| 102. HIV Testing |
April 20, 2008 |
102.doc |
102.pdf |
| 483. Immune Restoration Syndrome |
April 18, 2008 |
483.doc |
483.pdf |
| 400. HIV Life Cycle |
April 18, 2008 |
400.doc |
400.pdf |
| 106. HIV Life Cycle |
April 18, 2008 |
106.doc |
106.pdf |
| 726. Echinacea |
April 15, 2008 |
726.doc |
726.pdf |
| 725. DNCB (Dinitrochlorobenzene) |
April 15, 2008 |
725.doc |
725.pdf |
| 803. Smoking and HIV |
April 14, 2008 |
803.doc |
803.pdf |
| 802. Exercise and HIV |
April 14, 2008 |
802.doc |
802.pdf |
| 551. Fatigue |
April 14, 2008 |
551.doc |
551.pdf |
| 550. Side Effects |
April 14, 2008 |
550.doc |
550.pdf |
| 538. Atovaquone (Mepron) |
April 14, 2008 |
538.doc |
538.pdf |
| 531. Ciprofloxacin (Cipro) |
April 14, 2008 |
531.doc |
531.pdf |
| 204. Telling Others You are HIV Positive |
April 14, 2008 |
204.doc |
204.pdf |
| 203. Medical Appointments |
April 14, 2008 |
203.doc |
203.pdf |
| 158. AIDS Myths and Misunderstandings |
April 14, 2008 |
158.doc |
158.pdf |
| 153. Condoms |
April 14, 2008 |
153.doc |
153.pdf |
| 403. What Is Antiretroviral Therapy (ART)? |
April 13, 2008 |
403.doc |
403.pdf |
| 402. Drug Names and Manufacturers |
April 13, 2008 |
402.doc |
402.pdf |
| 611. Pregnancy and HIV |
April 12, 2008 |
611.doc |
611.pdf |
| 430. Non-Nucleoside Reverse Transcriptase Inhibitors in Development |
April 12, 2008 |
430.doc |
430.pdf |
| 401. Taking Current Antiretroviral Drugs (2 pages) |
April 12, 2008 |
401.doc |
401.pdf |
| 450. Darunavir (Prezista) |
March 29, 2008 |
450.doc |
450.pdf |
| 447. Atazanavir (Reyataz) |
March 28, 2008 |
447.doc |
447.pdf |
| 553. Body Shape Changes (Lipodystrophy) |
March 19, 2008 |
553.doc |
553.pdf |
| 460. Attachment and Fusion Inhibitors in Development |
March 18, 2008 |
460.doc |
460.pdf |
| 515. Pneumocystis Pneumonia (PCP) |
March 12, 2008 |
515.doc |
515.pdf |
| 415. Lamivudine (Epivir) |
February 8, 2008 |
415.doc |
415.pdf |
| 480. Immune Therapies in Development |
February 7, 2008 |
480.doc |
480.pdf |
| 410. Nucleoside Analog Reverse Transcriptase Inhibitors in Development |
February 7, 2008 |
410.doc |
410.pdf |
| 404. U.S. Antiretroviral Therapy Guidelines |
February 4, 2008 |
404.doc |
404.pdf |
| 470. Other Antiretroviral Drugs in Development |
February 3, 2008 |
470.doc |
470.pdf |
| 432. Efavirenz (Sustiva) |
January 30, 2008 |
432.doc |
432.pdf |
| 201. How Do I Start? |
January 30, 2008 |
201.doc |
201.pdf |
| 124. CD4 (T-cell) Tests |
January 30, 2008 |
124.doc |
124.pdf |
| 434. Etravirine (Intelence) |
January 20, 2008 |
434.doc |
434.pdf |
| 406. Treatment Interruptions |
January 17, 2008 |
406.doc |
406.pdf |
| 612. Children and HIV |
December 30, 2007 |
612.doc |
612.pdf |
| 445. Amprenavir (Agenerase) |
November 25, 2007 |
445.doc |
445.pdf |
| 510. Human Papillomavirus (HPV) |
November 21, 2007 |
510.doc |
510.pdf |
| 208. Selling Your Life Insurance |
November 17, 2007 |
208.doc |
208.pdf |
| 446. Lopinavir + ritonavir (Kaletra) |
November 13, 2007 |
446.doc |
446.pdf |
| 479. Hydroxyurea (Hydrea) |
November 8, 2007 |
479.doc |
479.pdf |
| 422. Epzicom (Kivexa, abacavir + lamivudine) |
November 8, 2007 |
422.doc |
422.pdf |
| 417. Combivir (zidovudine + lamivudine) |
November 7, 2007 |
417.doc |
417.pdf |
| 414. Stavudine (Zerit, d4T) |
November 7, 2007 |
414.doc |
414.pdf |
| 413. Didanosine (Videx, ddI) |
November 7, 2007 |
413.doc |
413.pdf |
| 412. Zalcitabine ((Hivid, ddC) |
November 7, 2007 |
412.doc |
412.pdf |
| 411. Zidovudine (Retrovir, AZT) |
November 7, 2007 |
411.doc |
411.pdf |
| 651. HIV and Kidney Disease |
October 22, 2007 |
651.doc |
651.pdf |
| 505. Dementia and Nervous System Problems |
October 22, 2007 |
505.doc |
505.pdf |
| 448. Fosamprenavir (Telzir, Lexiva) |
October 19, 2007 |
448.doc |
448.pdf |
| 511. Kaposis Sarcoma (KS) |
October 14, 2007 |
511.doc |
511.pdf |
| 471. Raltegravir (Isentress) |
October 5, 2007 |
471.doc |
471.pdf |
| 461. Enfuvirtide (Fuzeon) |
October 4, 2007 |
461.doc |
461.pdf |
| 129. Tropism Tests |
October 4, 2007 |
129.doc |
129.pdf |
| 702. Ayurvedic Medicine |
September 28, 2007 |
702.doc |
702.pdf |
| 558. Depression and HIV |
September 28, 2007 |
558.doc |
558.pdf |
| 533. Dapsone (Avlosulfon) |
September 28, 2007 |
533.doc |
533.pdf |
| 509. Herpes Zoster (Shingles) |
September 28, 2007 |
509.doc |
509.pdf |
| 500. Opportunistic Infections |
September 28, 2007 |
500.doc |
500.pdf |
| 443. Saquinavir (Invirase) |
September 28, 2007 |
443.doc |
443.pdf |
| 155. Harm Reduction and HIV |
September 28, 2007 |
155.doc |
155.pdf |
| 125. Viral Load Tests |
September 28, 2007 |
125.doc |
125.pdf |
| 105. How HIV Drugs Get Approved |
September 28, 2007 |
105.doc |
105.pdf |
| 103. Acute HIV Infection |
September 28, 2007 |
103.doc |
103.pdf |
| 101. What is AIDS? |
September 28, 2007 |
101.doc |
101.pdf |
| 555. Peripheral Neuropathy |
September 22, 2007 |
555.doc |
555.pdf |
| 444. Nelfinavir (Viracept) |
September 20, 2007 |
444.doc |
444.pdf |
| 440. Protease Inhibitors in Development |
September 12, 2007 |
440.doc |
440.pdf |
| 554. Diarrhea |
August 24, 2007 |
554.doc |
554.pdf |
| 206. How to Spot HIV/AIDS Fraud |
August 24, 2007 |
206.doc |
206.pdf |
| 205. Participating in a Clinical Trial |
August 24, 2007 |
205.doc |
205.pdf |
| 156. Treatment After Exposure to HIV |
August 24, 2007 |
156.doc |
156.pdf |
| 518. Tuberculosis (TB) |
August 18, 2007 |
518.doc |
518.pdf |
| 416. Abacavir (Ziagen) |
August 17, 2007 |
416.doc |
416.pdf |
| 408. Salvage Therapy |
August 17, 2007 |
408.doc |
408.pdf |
| 462. Maraviroc (Selzentry, Celsentri) |
August 16, 2007 |
462.doc |
462.pdf |
| 431. Nevirapine (Viramune) |
August 16, 2007 |
431.doc |
431.pdf |
| 729. St. Johns Wort (Hypericin) |
July 23, 2007 |
729.doc |
729.pdf |
| 557. Bone Problems |
July 23, 2007 |
557.doc |
557.pdf |
| 556. Mitochondrial Toxicity |
July 23, 2007 |
556.doc |
556.pdf |
| 537. Pentamidine |
July 23, 2007 |
537.doc |
537.pdf |
| 517. Toxoplasmosis |
July 23, 2007 |
517.doc |
517.pdf |
| 514. Mycobacterium Avium Complex (MAC) |
July 23, 2007 |
514.doc |
514.pdf |
| 512. Lymphoma |
July 23, 2007 |
512.doc |
512.pdf |
| 506. Hepatitis: Overview |
July 23, 2007 |
506.doc |
506.pdf |
| 449. Tipranavir (Aptivus) |
July 23, 2007 |
449.doc |
449.pdf |
| 439. Atripla (efavirenz + emtricitabine + tenofovir) |
July 23, 2007 |
439.doc |
439.pdf |
| 419. Tenofovir (Viread) |
July 23, 2007 |
419.doc |
419.pdf |
| 418. Trizivir (zidovudine + lamivudine + abacavir) |
July 23, 2007 |
418.doc |
418.pdf |
| 405. Adherence |
July 18, 2007 |
405.doc |
405.pdf |
| 151. Safer Sex Guidelines |
July 18, 2007 |
151.doc |
151.pdf |
| 157. Microbicides |
June 29, 2007 |
157.doc |
157.pdf |
| 727. Essiac |
June 25, 2007 |
727.doc |
727.pdf |
| 536. Filgrastim (Neupogen) |
June 25, 2007 |
536.doc |
536.pdf |
| 535. Trimethoprim/Sulfamethoxazole |
June 25, 2007 |
535.doc |
535.pdf |
| 481. Immune Restoration |
June 25, 2007 |
481.doc |
481.pdf |
| 152. How Risky Is It? |
June 25, 2007 |
152.doc |
152.pdf |
| 128. Body Composition Tests |
June 25, 2007 |
128.doc |
128.pdf |
| 123. Blood Sugar and Fats |
June 25, 2007 |
123.doc |
123.pdf |
| 494. Recreational Drugs and HIV |
May 14, 2007 |
494.doc |
494.pdf |
| 154. Drug Use and HIV |
May 14, 2007 |
154.doc |
154.pdf |
| 800. Nutrition |
May 13, 2007 |
800.doc |
800.pdf |
| 724. DHEA |
May 13, 2007 |
724.doc |
724.pdf |
| 722. Cats Claw (Uņa de Gato) |
May 13, 2007 |
722.doc |
722.pdf |
| 708. Native American Traditional Healing |
May 13, 2007 |
708.doc |
708.pdf |
| 704. Chinese Herbalism |
May 13, 2007 |
704.doc |
704.pdf |
| 703. Chinese Acupuncture |
May 13, 2007 |
703.doc |
703.pdf |
| 532. Clarithromycin (Biaxin) |
May 13, 2007 |
532.doc |
532.pdf |
| 530. Azithromycin (Zithromax) |
May 13, 2007 |
530.doc |
530.pdf |
| 513. Molluscum |
May 13, 2007 |
513.doc |
513.pdf |
| 442. Ritonavir (Norvir) |
May 13, 2007 |
442.doc |
442.pdf |
| 441. Indinavir (Crixivan) |
May 13, 2007 |
441.doc |
441.pdf |
| 433. Delavirdine (Rescriptor) |
May 13, 2007 |
433.doc |
433.pdf |
| 150. Stopping the Spread of HIV |
May 13, 2007 |
150.doc |
150.pdf |
| 121. Complete Blood Count (CBC) |
May 13, 2007 |
121.doc |
121.pdf |
| 126. HIV Resistance Testing |
May 12, 2007 |
126.doc |
126.pdf |
 |
 |
The AIDS InfoNet is a project of the New
Mexico AIDS Education and Training Center at the University of New Mexico Health
Sciences Center. |
 |
|
Partially funded by the National Library of Medicine |
|